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Dissociation pathways of alkali-cationized peptides have been studied using multiple stages of
mass spectrometry (MSx) with a quadrupole ion trap mass spectrometer. Over 100 peptide ions
ranging from 2 to 10 residues in length and containing each of the 20 common amino acids
have been examined. The formation of the [bn21 1 Na 1 OH]
1 product ion is the predomi-
nant dissociation pathway for the majority of the common amino acids. This product
corresponds to a sodium-cationized peptide one residue shorter in length than the original
peptide. In a few cases, product ions such as [bn21 1 Na 2 H]
1 and those formed by loss, or
partial loss, of a sidechain are observed. Both [bn21 1 Na 1 OH]
1 and [bn21 1 Na 2 H]
1
product ions can be selected as parent ions for a subsequent stage of tandem mass
spectrometry (MS/MS). It is shown that these dissociation patterns provide opportunities for
peptide sequencing by successive dissociation from the C-terminus of alkali-cationized
peptides. Up to seven stages of MS/MS have been performed on a series of [b 1 Na 1 OH]1
ions to provide sequence information from the C-terminus. This method is analogous to
Edman degradation except that the cleavage occurs from the C-terminus instead of the
N-terminus, making it more attractive for N-terminal blocked peptides. The isomers leucine
and isoleucine cannot be differentiated by this method but the isobars lysine and glutamine
can. (J Am Soc Mass Spectrom 2001, 12, 497–504) © 2001 American Society for Mass
Spectrometry
In recent years, tandem mass spectrometry (MS/MS)has become a powerful technique for sequencingpeptides and small proteins. Typically, the proton-
ated peptide of interest is isolated from other ions in the
mass spectrum. This ion then undergoes collision-in-
duced dissociation (CID), forming product ions from
which the primary sequence of the peptide can be
deduced [1–6]. Although MS/MS spectra of protonated
peptides provide substantial sequence information, the
spectra are often complicated and do not reveal the
complete sequence. When a peptide is from a protein in
a database, it is often possible to identify the peptide
from the molecular weight and a partial sequence,
typically called a “sequence tag” [7]. Use of partial
sequences in addition to molecular weight is becoming
a standard approach in the field of proteomics [8].
CID of alkali-cationized peptides, [M 1 Cat]1
(Cat 5 alkali metal ions), has been studied by a number
of research groups [9–27]. Alkali metal ions were
thought to interact selectively with polar functional
groups and CID of the alkali-cationized molecule to
occur via “charge-remote” fragmentations. These stud-
ies were based on the early work of Rollgen and
co-workers [28], who first showed the CID spectra of
[M 1 Cat]1 ions to be significantly different from those
of the analogous [M 1 H]1 ions. Subsequently, there
have been a number of studies of the gas-phase chem-
istry of complexes between alkali metal ions and pep-
tides. McLafferty et al. first demonstrated that CID of
laser desorbed [M 1 K]1 of gramicidin D and S gives
useful structural information [29]. Other researchers
have focused on the reaction mechanism or structure of
the gas phase ion. The most detailed studies, by the
groups of Gross [9, 10] and Adams [11–13], used
MS/MS on sector instruments to investigate the gas-
phase interactions of alkali metal ions and small pep-
tides. Several possible mechanisms for fragmentation
have been proposed. However, each results in –OH
transfer (or –OCat, depending upon the structure of the
ion) from the C-terminus to the adjacent amino acid
along with loss of the C-terminal residue from the
parent peptide ion, presumably as CO and an imine.
The product ion that is formed is [bn21 1 Cat 1 OH]
1
according to conventional nomenclature [30]. The initial
peptide ion [M 1 Cat]1 is equivalent to [bn 1 Cat 1
OH]1. This parent ion is postulated to have the same
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alkali interactions as the product ion [bn21 1 Cat 1
OH]1. Thus, each subsequent product ion is equivalent
to a new alkali-cationized peptide, only one residue
shorter than the initial peptide. Although the previ-
ously published results show the ability to identify the
C-terminal residue, there were typically many other
competitive dissociation pathways observed in the sec-
tor MS/MS spectra. The rearrangement reaction that
forms the [bn21 1 Cat 1 OH]
1 ion was often observed
to be a major metastable process, which suggests that
this reaction has a low critical energy [9–13]. The low
critical energy has been confirmed by kinetic energy
loss measurements performed in our laboratory.
Quadrupole ion trap mass spectrometers often have
high specificity and sensitivity for low-energy processes
due to their collision energetics (very low center-of-
mass collision energies) and their time frame for CID
(tens to hundreds of milliseconds or more). Further-
more, the multistage MS/MS capability, MSx (x is being
used instead of the customary n to avoid confusion with
the peptide ion nomenclature), of the quadrupole ion
trap extends its potential to obtain sequence informa-
tion.
The objective of this work is to study the dissociation
pathways of the 20 common amino acids when they are
the C-terminal residues of the alkali-cationized peptide,
and to investigate the potential of using alkali-cation-
ized peptides and the MSx capability of the quadrupole
ion trap as a new approach to obtaining sequence
information for peptides. Over 100 peptide ions, rang-
ing from 2 to 10 residues in length were examined to
determine the general applicability and the limitations
of this approach.
Experimental
Sources of Peptides
The peptides used were obtained from various sources. (1)
Custom synthesized: YGLFL, YGPFL, YGSFL, YGWFL,
and YGRFL were synthesized in the Peptide Synthesis
Lab in the Department of Chemistry at UNC. These were
used as received without further purification. VGED,
YGGFI, YGGFC, YGGCL, FGGYL, GGGGGGG, LGGAL,
and FYGPV were synthesized by Dr. Barney Bishop from
the Department of Chemistry at UNC. These were used as
received without further purification. LLFGYPVYV was
obtained from Dr. David Klapper from the Department of
Biochemistry at UNC and was used as received without
further purification. Crude peptides GVAYFMVHPD,
FAVYLHMCIS, LFAVYIHMPN, and VLYAHPICFW
were obtained from Research Genetics (Huntsville, AL);
VAYFMHPS, VAYFMHPT, VAYFMHPN, VAYFMHPQ,
and VAYFMHPW were obtained from Bio z Synthesis
(Lowisville, TX). These peptides were purified by HPLC
before mass spectrometric analysis. (2) Fragments from
Protein Digest: Myoglobin was digested with pepsin at
pH ;2–3 at room temperature for 10–15 min, and then
separated by high performance liquid chromatography
(HPLC). Approximately 30 peptide fragments were col-
lected. Samples were dried with a speed vacuo, and then
redissolved in 50/50 H2O/MeOH. (3) YGGFL, YGGFLR,
YGGFM, AGSE, VGDE, VIHN, DLWQK, GRGD, GGH,
FLEEI, RYLPT, RKEVY, FLEEV, AAAAA, GGGG,
RPPGFSPF, pEKWAP, YYYYYY, YGGFL–NH2, KEEAE,
TRSAW, SSS, GRGDNP, VHLTP, YGGFMK, KKKK,
WHWLQL, PPGFSP, EAEN, VGVAPG, PPGFSPFR,
GVYVHPV, and SarVYIHPI, were obtained from Sigma
Chemical (St. Louis, MO). These were used as received
without further purification.
Quadrupole Ion Trap Mass Spectrometry
Quadrupole ion trap experiments were performed with
a modified Finnigan (San Jose, CA) quadrupole ion trap
mass spectrometer controlled by Finnigan Rev. B ITMS
and ICMS-FL [31] software. Alkali-cationized peptide
ions were generated with a custom-built electrospray
ionization source from solution mixtures of peptides in
50:50 methanol:water with added sodium or lithium
bicarbonate (typically a 1:5 mole ratio of peptide:salt).
Helium was used as the bath gas and to effect CID at a
typical pressure of 1 3 1023 torr in the ion trap [32, 33].
Calculations
Modified neglect of differential overlap (MNDO) calcu-
lations were performed with the MOPAC 6.0 package.
Starting peptide structures were generated with PC-
MODEL (Serena Software). The structures were then
optimized to the local energy minimum, and the heats
of formation and bond lengths were then obtained from
these structures.
Results and Discussion
CID of [M 1 H]1 vs. [M 1 Na]1
Protonated peptides are most often used as the parent
ions in MS/MS experiments to generate sequence infor-
mation. Typically, a variety of product ions are formed
during CID of protonated peptides, including dissocia-
tion from both the C-terminus (a and b ions) and the
N-terminus (y ions). Errors in interpreting the type of
product ions formed can lead to errors in the sequence
deduced from the MS/MS spectrum.
The top spectrum in Figure 1 shows the typical
MS/MS spectrum of a protonated peptide using a
quadrupole ion trap mass spectrometer. In this case,
[YGGFL 1 H]1 was mass selected (m/z 556) and sub-
jected to CID. Many types of product ions were ob-
served in the MS/MS spectrum. These include N-
terminal product ions (e.g., a4 at m/z 397 and b4 at m/z
425) and C-terminal product ions (e.g., y3 at m/z 336 and
y2 at m/z 279), as well as product ions that have
dissociated at each terminus [e.g., (b4y
3)2 at m/z 204 and
(b4y4)3 at m/z 261]. Although the sequence probably
could be determined if this was an unknown, even this
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relatively short peptide gives a complex MS/MS spec-
trum.
As a comparison to the MS/MS spectrum of the
protonated peptide, the bottom spectrum in Figure 1
shows the MS/MS spectrum of the same peptide,
ionized by sodium ion attachment. All the product ions
formed are the result of cleavage of the C-terminal
peptide bond or adjacent bonds. By far the dominant
peak is the [b4 1 Na 1 OH]
1 ion (m/z 465), produced
by the rearrangement reaction. If this compound were
an unknown, the loss of 113 Da would indicate that
either leucine or isoleucine is the C-terminal residue.
The MS/MS efficiency for this stage of analysis, defined
as the sum of the intensities of the product ions divided
by the initial parent ion intensity [34], is 100%. The
conversion efficiency to the rearrangement ion, defined
as the ratio of the intensity of one product ion to the
initial intensity of the parent ion [35], is 83%. The
product ion, [b4 1 Na 1 OH]
1, is empirically the same
as the sodiated tetrapeptide YGGF. MS3 of a [bn21 1
Na 1 OH]1 ion produces virtually the same product
ion spectrum as MS/MS of a (M 1 Na)1 ion.
Characteristic Dissociations of the 20 Common
Amino Acids
The characteristic dissociations of the 20 common
amino acids were studied when they were the C-
terminal residues of an alkali-cationized peptide. Over
100 peptide ions ranging from 2 to 10 residues in length
have been studied, and almost all of the dissociations
observed involve the C-terminal residue. All the amino
acids fall into one of two general categories of dissoci-
ations when they are the C-terminal residues of the
alkali-cationized peptide. The majority of amino acids
undergo the rearrangement and loss of the C-terminal
residue as described above and are classified as cate-
gory I amino acids. Peptides with C-terminal category I
amino acids dissociate to form the [bn21 1 Na 1 OH]
1
product ion as the predominant dissociation pathway.
The rest of the amino acids, category II, typically form
the alkali-cationized analog of the bn and bn21 ions (i.e.,
[bn 1 Na 2 H]
1). The following discussion describes
the two categories of dissociation.
Category I amino acids. Fifteen amino acids are in-
cluded in category I. The dissociation patterns of these
peptides are listed in Table 1. The dissociation pattern is
largely determined by the C-terminal peptide, and not
by the entire peptide sequence. Thus, the average
relative intensities and standard deviations for each
product ion are given for each amino acid when it is the
C-terminal residue. Of the 15 amino acids in category I,
10 of them dissociate by producing almost exclusively
[bn21 1 Na 1 OH]
1 product ions. These 10 are ala-
nine, valine, leucine, isoleucine, methionine, proline,
phenylalanine, tyrosine, lysine, and histidine, and they
comprise a subcategory, Ia.
The bottom spectrum in Figure 1 shows typical
dissociation pathways of peptides with C-terminal cat-
egory Ia amino acids. Shown in this figure is an MS/MS
spectrum with leucine as the C-terminal residue. The
[b4 1 Na 1 OH]
1 product ion dominates the MS/MS
spectrum, with a conversion efficiency of 83%. If leucine
is replaced with a methionine, a virtually identical
MS/MS spectrum is observed for YGGFM, with 90%
conversion efficiency. From the information summa-
rized in Table 1, several general trends were observed
for the dissociation of alkali-cationized peptides under
the low-energy CID conditions of the quadrupole ion trap.
(1) Peptide length: For the 10 category Ia amino
acids, the length of the peptide does not affect the
MS/MS dissociation pathways for peptides three to
nine residues long. (We cannot generate significant
intensity of the singly cationized peptides for longer
peptides using electrospray ionization.) Figure 2 shows
the dissociation pathways for isoleucine as the C-
terminal residue of a pentapeptide YGGFI, or a hep-
tapeptide SarVYIHPI. Although protonated peptides
with proline typically undergo facile cleavage on the
N-terminus side of proline [36] this does not occur for
sodiated SarVYIHPI. Virtually the same dissociation
pathways were observed for the two isoleucine C-
terminated peptides, with [bn21 1 Na 1 OH]
1 as the
dominant peak in the MS/MS spectrum. In general, the
length of the peptide is observed to have no influence
on the dissociation pathway.
(2) Effect of adjacent residue: The amino acid that is
adjacent to the C-terminal residue has little influence on
the observed dissociation pathway of that C-terminal
residue. For example, YGGFI and SarVYIHPI both have
isoleucine at the C-terminus. Although the adjacent resi-
due is different (phenylalanine and proline, respectively),
the MS/MS dissociation pathway is virtually the same, as
shown in Figure 2.
Figure 1. (Top) MS/MS of [YGGFL 1 H]1. (Bottom) MS/MS of
[YGGFL 1 Na]1.
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(3) Effect of N-terminal residue: As expected, the
N-terminus has little effect on the dissociation pathway
of C-terminal residue if the peptide has three residues
or more. For example, CID of [b6 1 Na 1 OH]
1 ions
from SarVYIHP and GVYVHP show essentially identi-
cal dissociation pathways. The conversion efficiency is
25%, and the [b5 1 Na 1 OH]
1, [b5 1 Na 2 H]
1, and
[a5 1 Na 2 H]
1 ions are also observed for both. The
N-terminal blocked peptide, pEKWAP, also showed
little effect of the N-terminal residue on the dissociation
pathway upon CID.
Three of the amino acids in category I, cysteine,
arginine, and glutamic acid, comprise a subcategory Ib.
They dissociate to form predominantly [bn21 1 Na 1
OH]1 product ions together with other characteristic
product ions of significant relative intensity. These
other product ions are a result of partial sidechain loss.
Figure 3 shows a typical MS/MS spectrum of a
cysteine-containing peptide. The [b3 1 Na 1 OH]
1 ion
is still the dominant product ion in the CID spectrum of
the tetrapeptide YGGC, but other product ions include
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Figure 2. (Top) MS/MS of [YGGFI 1 Na]1. (Bottom) MS/MS of
[SarVYIHPI 1 Na]1.
Figure 3. MS/MS of [YGGC 1 Na]1 loss of 34 5 SH2.
500 LIN ET AL. J Am Soc Mass Spectrom 2001, 12, 497–504
those formed by partial loss of the sidechain, such as
[b4 1 Na 1 OH 2 34]
1 and [a4 1 Na 1 OH 2 34]
1.
This loss of 34 Da, corresponding to the H2S molecule,
has been observed exclusively with peptides containing
cysteine. Thus, it can be used as supplementary infor-
mation for cysteine identification.
When arginine is at the C-terminus of an alkali-
cationized peptide, in addition to the main product ion
[bn21 1 Na 1 OH]
1, [M 1 Na 2 H2O 2 42]
1 is a
characteristic product ion observed in the MS/MS spec-
trum. Loss of 42 Da can be assumed to be part of the
sidechain of the arginine residue (NH¢C¢NH). Such
dissociation has been previously reported [11–13, 24].
An example is shown in Figure 4 for the peptide
YGGFLR. The base peak is [b5 1 Na 1 OH]
1, but the
product ion formed by the loss from the sidechain,
[b6 1 Na 2 H 2 42]
1, is significant (relative intensi-
ty 5 22%). With this additional information, the deter-
mination of C-terminal arginine can be made with
increased confidence.
An example of glutamic acid dissociation can be seen
in Figure 5. Here, although the [b4 1 Na 1 OH]
1 is still
the base peak in the MS/MS spectrum, [bn-2 1 Na 1
OH 2 58]1 is observed with a significant abundance of
76%, resulting from loss of CH2CO2 from the sidechain
of an internal glutamic acid. This information can be
used to confirm the existence of glutamic acid in the
peptide sequence; however, this product ion is not
universal among all peptides containing this amino
acid.
The remaining two amino acids in category I, glycine
and aspartic acid, have a caveat associated with their
behavior and fall into a subcategory denoted Ic. These
two amino acids dissociate like the category Ia amino
acids when the peptides are more than three residues
long. However, these residues dissociate like category II
residues when the peptides are three residues or
shorter.
For glycine, this is shown in the cases of GGGG,
GGGGGGG, and VGVAPG, where each peptide disso-
ciates by producing the rearrangement product ion
[bn21 1 Na 1 OH]
1 as the base peak in the MS/MS
spectra. However, when the C-terminal glycine is the
third residue from the N-terminus (e.g., YGG), [bn21 1
Na 1 OH]1 product ions are usually no longer gener-
ated consistently or predominantly. Thus, it is more
difficult to determine the sequence of the last two
residues (YG) because the product ion spectrum does
not have the rearrangement ion as the major product
ion. However, the presence of significant amount of
[b2 1 Na 2 H]
1 (relative intensity 5 20%) and [a2 1
Na 2 H]1 (relative intensity 5 22%) ions together with
the rearrangement ion [b2 1 Na 1 OH]
1 (relative inten-
sity 5 25%) make it possible to identify the C-terminal
residue as glycine. This change of dissociation path-
ways, although not common, is typical of three residue
peptides when glycine is on the C-terminus.
As an example of aspartic acid dissociation in short
peptides, VGD produces a [(b3y1)1 1 Na 1 OH]
1
product ion, i.e., [D 1 Na 1 OH]1, as the base peak in
the MS/MS spectrum. It is assumed that for short
peptides (di- and tripeptides), intramolecular interac-
tions occur between the N- and C-termini that change
the dissociation pathways. Gross et al. reported MS/MS
results for dipeptides that are completely different from
what is observed for longer peptides. In part, the
category Ic dissociation patterns may be due to the
cation being able to coordinate to both the C- and
N-termini in the short peptides [9, 10, 37].
Category II amino acids. The remaining five amino
acids, tryptophan, serine, threonine, asparagine, and
glutamine compose category II. Although the [bn21 1
Na 1 OH]1 product ions are often observed for pep-
tides with C-terminal category II amino acids, they are
almost never the base peak in the MS/MS spectra.
Instead, peptides with these C-terminal amino acids
typically dissociate to alkali-cationized analogs of bn or
bn21 ions. Other dissociations include loss of N-termi-
nal residues and loss, or partial loss, of the sidechain.
Some of these other dissociations become dominant
when the peptide is short (three or fewer residues),
which again may indicate intramolecular interactions
between the N- and C-termini. Results from category II
amino acids are summarized in Table 2. The intensities
of each product ion is given as the average and stan-
dard deviation observed for several different peptides
with the same residue at the C-terminus. In Table 1, the
category I residues clearly favor the formation of the
Figure 4. MS/MS of [YGGFLR 1 Na]1 loss of 42 5 NH¢C¢NH.
Figure 5. MS/MS of [KEEAE 1 Na]1.
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[bn21 1 Na 1 OH]
1 product ion as can be seen by the
high average intensities and relatively low standard
deviations in this column. The category Ic residues have
more variability due to the inclusion of short peptides
into these averages, which do not favor the [bn21 1
Na 1 OH]1 product ion. Likewise, in Table 2, the
standard deviations are very large compared to those in
Table 1, indicating that the dissociation pattern is not
consistently among different peptides with the same
C-terminal residue. Also, no one column has the highest
average intensities as no one type of product ion is
consistently the dominant product.
Serine and threonine C-terminated peptides have
very similar dissociation pathways. Although the
[bn21 1 Na 1 OH]
1 product ion was observed for all
the peptides studied that contain serine and threonine,
it was never the base peak in the MS/MS spectrum.
Instead, the product ions that are formed by loss of H2O
to give [bm 1 Na 2 H]
1 (m # number of residues in
the peptide) tend to be favored. Water loss is not
surprising for peptides with a hydroxyl sidechain. A
characteristic product ion is formed by a loss of 62 Da,
[bn 1 Na 2 H 2 44]
1, loss of water from the sodiated
peptide followed by loss of 44. Because 44 presumably
corresponds to CO2, the so-called [bm 1 Na 2 H]
1
may in fact actually be due to loss of the hydroxyl from
the sidechain (as H2O) and not from the C-terminus.
This particular product ion is especially notable when
serine or threonine is located four or more residues
away from the N-terminus. Although CID of PPGFS
produces [bn 1 Na 2 H 2 44]
1 in significant abun-
dance, 21%, this product ion is not observed for the
shorter peptides YGS and AGS. Instead, dissociation of
residues from the N-terminus as well as from the
C-terminus is observed. This is another piece of evi-
dence supporting the hypothesis that some three-resi-
due peptides have interactions occurring between the
C- and N-termini. CID of both YGS and AGS produces
[(b3y1)1 1 Na 1 OH]
1 product ion, i.e., [S 1 Na 1
OH]1, at relative intensities of 35% and 100%, respec-
tively. The dissociation of threonine is very similar to
serine. (See Table 2 for detail.)
Asparagine and glutamine are structurally related
residues, i.e., both are amides, and show some similar
dissociation pathways when they are the C-terminal
residues of alkali-cationized peptides. Most of the pep-
tides with asparagine or glutamine as the C-terminal
residue dissociate by loss of NH3. For example, this
product ion, [M 1 Na 2 NH3]
1, is observed as the base
peak for both the peptides VIHN and WHWLQ (results
for other N/Q terminated peptides are similar). The
loss of NH3 from peptides with glutamine as the
C-terminal residue is very important because it allows
the differentiation from the isobaric residue, lysine.
Besides loss of NH3, asparagine sometimes also
exhibits a characteristic subsequent loss of 72 Da. It
appears after CID of either the sodium cationized
peptide or of the [M 1 Na 2 NH3]
1 product ion. This
is assumed to be the partial loss of the asparagine
sidechain (CO) simultaneously with a part of the back-
bone (CO2). This loss of 72 Da is found to be specific for
asparagine when it is the C-terminal residue of the
alkali-cationized peptide. Thus, it can be used as a
characteristic dissociation to identify the existence of
asparagine. However, no such characteristic dissocia-
tion has been observed for glutamine.
Tryptophan C-terminated peptides behave differ-
ently from all the rest of the peptides and are the only
ones that do not appear to have a predictable dissocia-
tion pattern. In the CID spectrum of YGW, [b2 1 Na 1
OH]1 is observed as the base peak. However, with
TRSAW, the [b5 1 Na 2 H]
1 ion (loss of H2O from the
alkali-cationized peptide) is the base peak in the
MS/MS spectrum. The [b4 1 Na 1 OH]
1 rearrange-
ment product ion is only a minor peak (relative inten-
sity 5 11%). A product ion corresponding to [M 1
Na 2 44]1 (relative intensity 5 78%) is also observed
in the spectrum, but how the ion is formed is currently
unknown. It may be that the serine in this particular
peptide is influencing the dissociation pathways.
Opportunities for peptide sequencing. Up to eight stages
of MS/MS have been performed on a series of [b 1
Na 1 OH]1 ions to provide sequence information from
the C-terminus. An example of this can be seen in our
previous publication [27]. Sequential dissociation (M 1
Table 2. Dissociation pathways of category II amino acids when they are the C-terminal residues of the sodium cationized peptides
Amino
acid
peptides
bn 1 Na 2
H
an 1 Na 2
H
bn21 1 Na
1 OH
bn21 1 Na
2 H
an21 1 Na
2 H Others
Conversion
efficiency
(%)
Ser (S) 63.8 6 33.3 1.5 6 3.7 21.5 6 16.5 51.7 6 42.8 3.3 6 6.4 (bn 1 Na 2 H 2 44)
1 (20.2 6 40) 31.6 6 10.7
(S 1 Na 1 OH)1(22.5 6 40.5)
Thr (T) 63.0 6 35.2 0 6 0 11.3 6 2.3 38.0 6 54.2 13.3 6 23.1 (bn 1 Na 2 H 2 44)
1 (41.0 6 52.4) 32.0 6 7.2
(M 1 Na 2 44)1 (9.3 6 11.4)
Asn (N) 0 6 0 0 6 0 2.2 6 4.5 17.5 6 23.6 0 6 0 (M 1 Na 2 NH3)
1 (100 6 0) 34.0 6 17.0
(M 1 Na 2 NH3 2 72)
1 (3.0 6 6.0)
or (M 1 Na 2 NH3 2 72)
1 upon MS3
of (M 1 Na 2 MH3)
1
Gln (Q) 33.8 6 47.2 14.8 6 18.0 30.5 6 31.5 20.2 6 23.4 14.5 6 27.7 (M 1 Na 2 NH3)
1 (50 6 57.7) 31.3 6 22.2
Trp (W) 31.2 6 47.0 0 6 0 47.8 6 49.7 30.2 6 46.8 0.5 6 1.0 29.8 6 17.6
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Na)1 (m/z 792)3 (b6 1 Na 1 OH)
1 (m/z 693)3 (b5 1
Na 1 OH)1 (m/z 596)3 (b4 1 Na 1 OH)
1 (m/z 459)3
(b3 1 Na 1 OH)
1 (m/z 360) 3 (b2 1 Na 1 OH)
1 (m/z
197) 3 (b1 1 Na 1 OH)
1 (m/z 98) was observed, with
sequential loss of V, P, H, V, Y, and V from the
C-terminus. Thus the entire sequence of this peptide
can be readily determined from such series of spectra.
Semi-empirical calculations. The source of the differ-
ences in the dissociation patterns of the two categories
of amino acids depends on how the sodium ion directs
the dissociation. Because the two categories dissociate
differently, they must interact differently with the so-
dium ion. Semi-empirical calculations were performed
on several sodium-cationized peptides from both cate-
gories to explore why these peptides follow different
dissociation pathways. A difference in the preferred
location of the sodium ion or the conformation of the
peptide–ion complex for the two categories of C-termi-
nal residues could help to answer this question. Previ-
ous researchers’ results have led to conflicting conclu-
sions as to the location of the sodium ion in the
peptide–ion complex [9, 10, 12, 19, 38]. Because the
location of the sodium interaction is not known, the
peptides were modeled here with the sodium ion in a
variety of possible locations. The sodium ion was ini-
tially coordinated to the two oxygens of the C-terminus,
the nitrogen at the N-terminus, to each oxygen in the
internal carbonyls individually, or to pairs of adjacent
internal carbonyl oxygens in the calculations. Both the
zwitterionic and the neutral peptide were modeled, but
in all cases, the neutral peptide formed a complex
significantly lower in energy than that with the zwitte-
rion. Therefore, only the results from the neutral pep-
tide–sodium ion complex will be discussed. In addition,
the peptides were also modeled in two types of bond
angles. The first type used a-helix-like bond angles
resulting in a more compact structure. The second type
used b-sheet-like bond angles, which produced more
extended peptide models. The peptides modeled with
category I residues were YGGFL, YGGL, GGGG, and
GVYVH. The peptides YGGS, RGDS, and PPGFS rep-
resent the category II residues. YGG was modeled as a
short peptide with a category Ic residue. The proton-
ated version of each peptide was also modeled as a
reference to examine what changes the sodium ion
induces in the peptide.
Differences between the two categories were noted
regarding bond lengths. In some cases, peptide bonds
(between the C and N in the peptide backbone) are
lengthened by about 0.015 Å relative to the protonated
peptide. This lengthening is dependent on the location
of the sodium ion coordination, the type of bond angles,
and, sometimes, whether the C-terminal residue is
category I or II. When the peptides are in the compact
(a-helix type) configuration, no differences are ob-
served between the two categories. In these cases, the
C-terminal peptide bond is lengthened when the so-
dium ion is at the N-terminus.
The extended conformations (b-sheet type) have
different responses depending on the category of the
residue at the C-terminus. With category I residues, no
bond lengths are changed regardless of the location of
the sodium ion. Category II and Ic residues show a
dependence upon the location of the sodium ion. When
the sodium ion coordinates to the N-terminus, the
bonds are unchanged. However, when the sodium is at
the C-terminus of a peptide with a category II residue,
all of the peptide bonds are lengthened.
The lengthening of these bonds is of particular
interest because the peptide bonds are those broken to
form the b-type ions. The fact that the location of the
sodium ion and the three-dimensional conformation of
the peptide influence the bond lengths differently in the
two categories may indicate the origin of the two classes
of dissociation. If the site of sodium interaction is
different for category I and II residues, or if the confor-
mations of these peptides are different, this could
explain why the sodium ion influences the two catego-
ries differently.
[M 1 Na]1 and [M 1 Li]1 comparison. In addition to
sodiated peptides, lithium-cationized peptides were
also studied. It was found that for category I amino
acids, very little difference in the dissociation pathways
was observed between the spectra of sodium and
lithium-cationized peptides (data not shown). For cate-
gory II amino acids, lithium-cationized peptides also
have complicated dissociation pathways, which are
often similar to those of their sodium counterparts. For
example, in the dissociation of VGD, both sodium and
lithium cationized peptides generate [(b3y1)1 1 Cat 1
OH]1, i.e., [D 1 Cat 1 OH]1, as the most abundant
product ion.
However, different CID dissociation pathways are
sometimes observed for category II amino acids when
comparing lithium and sodium cationized peptides.
When lithium cationized AGS was investigated for
C-terminated serine, the dissociation pathway showed
[b3 1 Li 2 H]
1 as the main product ion with [b2 1
Li 1 OH]1, [b2 1 Li 2 H]
1, and [(b3y1)1 1 Li 1
OH]1, i.e., [S 1 Li 1 OH]1, at relative intensities 55%,
15%, and 42%, respectively. However, when the same
peptide was sodiated, the [(b3y1)1 1 Na 1 OH]
1, i.e.,
[S 1 Na 1 OH]1 ion was observed as the most abun-
dant product ion, with [b3 1 Na 2 H]
1 and [b2 1
Na 1 OH]1 of relative intensities 32% and 7%, respec-
tively. The changes in dissociation pathways may be
attributed to the size difference of lithium and sodium
ions, which under certain circumstances may influence
the binding of the alkali metal ion to the peptides,
making the dissociation pathways metal ligand depen-
dent.
Conclusion
These results using low-energy CID MS/MS in the
quadrupole ion trap with alkali-cationized peptides
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show that the dissociation pathways, particularly the
–OH group transfer and loss of the C-terminal residue
([bn 1 Na 1 OH]
1 3 [bn21 1 Na 1 OH]
1), are very
similar to those observed as metastable dissociations in
sector instruments by others [9–13]. A major distinction
of the current study is that only the C-terminal residue
and associated peptide linkages are involved in each
individual stage of tandem mass spectrometry, gener-
ating easily interpreted spectra. After acquiring a large
number of MS/MS spectra of alkali-cationized pep-
tides, two general categories of dissociation behavior
have been determined based on which of the 20 com-
mon amino acids is at the C-terminus. Fifteen amino
acids are in category I and five in category II. Peptides
with C-terminated category I amino acids usually dis-
sociate to form [bn21 1 Na 1 OH]
1 product ions,
which have the same structure as the parent ion [bn 1
Na 1 OH]1 (also [M 1 Na]1) but one residue shorter.
Although peptides with C-terminated category II amino
acids generally do not produce [bn21 1 Na 1 OH]
1
ion as the most abundant ion following CID, they do
provide other alkali-cationized analogs, such as bn or
bn21 ions and characteristic fragments. These dissocia-
tion patterns combined with the capability of ion trap-
ping instruments to affect multiple stages of MS/MS,
provide opportunities for a new method in peptide
sequencing.
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